Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer

To compare enzalutamide (E) and abiraterone acetate (AA) in terms of efficacy, survival and to characterize prognostic factors affecting survival in metastatic castration-resistant prostate cancer (mCRPC) patients. A total of 250 patients treated with E or AA in 5 centers were included. The number o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Demirci, Ayşe, Bilir, Cemil, Gülbağcı, Burcu, Hacıbekiroğlu, İlhan, Bayoğlu, İbrahim V., Bilgetekin, İrem, Koca, Sinan, Çınkır, Havva Y., Akdeniz, Nadiye, Gül, Deniz, Varım, Ceyhun, Demirci, Umut, Öksüzoğlu, Berna
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8266820/
https://ncbi.nlm.nih.gov/pubmed/34239026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-93659-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados